Suppr超能文献

对“PAK4抑制通过抑制Wnt/β-连环蛋白、p-ERK/MAPK和p-AKT/PI3K途径显著增强吉西他滨在胰腺导管腺癌细胞中的活性”的勘误 [《生物化学与生物物理报告》,(35),2023年9月,1 - 8 / 101544]

Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways" [Biochemistry and Biophysics Reports, (35), September 2023, 1-8 / 101544].

作者信息

Samant Charudatt, Kale Ramesh, Bokare Anand, Verma Mahip, Ranganath Pai K Sreedhara, Bhonde Mandar

机构信息

Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India.

Department of Pharmacology, Novel Drug Discovery and Development (NDDD), Lupin Limited, Survey No. 46A/47A, Village Nande, Taluka Mulshi, Pune, 412115, Maharashtra, India.

出版信息

Biochem Biophys Rep. 2025 Aug 9;43:102201. doi: 10.1016/j.bbrep.2025.102201. eCollection 2025 Sep.

Abstract

[This corrects the article DOI: 10.1016/j.bbrep.2023.101544.].

摘要

[本文更正了文章的数字对象标识符:10.1016/j.bbrep.2023.101544。]

相似文献

2
PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways.
Biochem Biophys Rep. 2023 Sep 9;35:101544. doi: 10.1016/j.bbrep.2023.101544. eCollection 2023 Sep.
5
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
J Cancer Res Clin Oncol. 2019 Dec;145(12):2921-2936. doi: 10.1007/s00432-019-03047-2. Epub 2019 Oct 16.
6
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis.
Neoplasia. 2025 Feb;60:101096. doi: 10.1016/j.neo.2024.101096. Epub 2024 Dec 30.
10
Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway.
IUBMB Life. 2024 Dec;76(12):1035-1049. doi: 10.1002/iub.2900. Epub 2024 Aug 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验